PACIFIC BIOTECH, INC. – Trademark Portfolio

Entity Type: 03

PACIFIC BIOTECH, INC. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. The owner is based in SAN DIEGO, CA.

8535 COMMERCE AVE.

SAN DIEGO, CA 92121

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CAMEO
CAMEO
Cancelled 1994
Q-S
Q-S
Cancelled 1992
CAMEO
CAMEO
Abandoned 1990
CONCISE
CONCISE
Cancelled 1990
O.S.
O.S.
Cancelled 1990
CICA
CICA
Cancelled 1989
PERFECT
PERFECT
Abandoned 1989
CARDS
CARDS
Cancelled 1988
CARDS +-
CARDS +-
Cancelled 1986

Trademark Classifications

PACIFIC BIOTECH, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does PACIFIC BIOTECH, INC. have?

PACIFIC BIOTECH, INC. has 15 U.S. trademarks filed with the USPTO.

What trademark classes does PACIFIC BIOTECH, INC. file in?

PACIFIC BIOTECH, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is PACIFIC BIOTECH, INC.'s trademark registration success rate?

PACIFIC BIOTECH, INC. has a 0% trademark registration rate, with 0 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.